FDA fruit-flavored e-cigarettes are facing renewed scrutiny after a newly released agency memo revealed that recently authorized mango and blueberry vaping products were not significantly more effective at helping smokers quit than tobacco-flavored alternatives. The disclosure is raising concerns among health experts and lawmakers who have questioned the agency’s decision to approve the products despite longstanding warnings about the appeal of sweet flavors to teenagers, as noted by Baltimore Chronicle.
FDA memo reveals limited evidence for flavored vape benefits
The U.S. Food and Drug Administration approved the fruit-flavored products from Glas Inc. last month. However, the agency’s newly published memo states that there were no statistically significant differences between smokers using mango or blueberry vapes and those using tobacco-flavored devices.
Previous approvals for flavored products, including menthol vapes from Juul and NJOY, relied on stronger evidence. Those studies showed higher quit rates among adults who used flavored products compared with tobacco-flavored options.
Key findings from the memo include:
- No significant advantage for mango and blueberry flavors.
- Adult smokers still switched from cigarettes at higher rates.
- FDA cited low expected youth usage as a major factor.
- Age verification is required through a smartphone application.
The findings have intensified debate over whether the products met the same regulatory standards applied to earlier vape authorizations.
Why the FDA approved the products anyway
FDA regulators argued that the Glas devices presented a lower risk of youth uptake because users must unlock the products through an age-verification system.
| Issue | FDA Position |
|---|---|
| Adult smoking cessation | Products may help smokers switch |
| Youth access risk | Considered relatively low |
| Flavor advantage | No significant benefit demonstrated |
| Security measure | App-based age verification |
The approval also appears to differ from recent FDA guidance, which stated that fruit and dessert flavors face a high evidentiary burden due to concerns about underage use.
Lawmakers demand more transparency
The controversy has attracted attention in Washington. Ten Democratic senators recently sent a letter to the FDA, describing the authorization as a reckless decision and requesting additional details.
Questions have also emerged about the unusually short FDA memo. Previous authorization documents often exceeded dozens of pages and included extensive scientific analysis. The Glas memo was only six pages long and omitted several details, including the number of smokers involved in the company’s research.
The decision marks another chapter in the ongoing debate over vaping regulation, public health, and the balance between helping adult smokers quit while preventing youth nicotine use.
Earlier we wrote that rabies alert in baltimore after foxes test positive near stony run park